AI-generated summary
The authors systematically reviewed 27 articles on photobiomodulation therapy used for cancer treatment toxicities such as oral mucositis, lymphedema, radiodermatitis, and peripheral neuropathy. They report that most studies observed no side effects, and conclude that the therapy does not appear to lead to tumor safety issues based on current literature.
- Studies included
- 27
- Who or what was studied
- Cancer patients receiving treatment, with toxicities such as oral mucositis, lymphedema, radiodermatitis, and peripheral neuropathy
- Limits stated in the abstract
- The abstract does not report the number of participants, the study designs, or the certainty of evidence, and the conclusion relies on the current literature.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Systematic review, Photobiomodulation, Low-level laser therapy, Oral mucositis, Neuropathy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.